Che Lin
Impact in
-
- Breast Cancer Treatment Studies
- Carcinogens and Genotoxicity Assessment
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Carcinogens and Genotoxicity Assessment 8
- Breast Cancer Treatment Studies 4
-
- Bioactive Compounds and Antitumor Agents 5
- Co-authors
- Dar‐Ren Chen (14 shared papers)Shou‐Jen Kuo (7 shared papers)Li-Sheng Chen (3 shared papers)Po-Hsiung Lin (9 shared papers)C.‐C. Tsai (1 shared paper)Ta‐Chen Lin (1 shared paper)Kuen‐Yao Ho (1 shared paper)Shou‐Tung Chen (3 shared papers)
In The Last Decade
Che Lin
20 papers receiving 391 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 106
- Biochemistry 41
- Toxicology 22
- Health, Toxicology and Mutagenesis 54
- Pathology and Forensic Medicine 33
Countries citing papers authored by Che Lin
This map shows the geographic impact of Che Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che Lin more than expected).
Fields of papers citing papers by Che Lin
This network shows the impact of papers produced by Che Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che Lin. The network helps show where Che Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Che Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 69 | |
| 2 | 2013 | 48 | |
| 3 | 2015 | 45 | |
| 4 | 2012 | 43 | |
| 5 | 2009 | 33 | |
| 6 | 2005 | 31 | |
| 7 | 2013 | 20 | |
| 8 | 2008 | 19 | |
| 9 | 2014 | 15 | |
| 10 | 2013 | 12 | |
| 11 | 2014 | 12 | |
| 12 | 2011 | 11 | |
| 13 | 2012 | 11 | |
| 14 | 2014 | 10 | |
| 15 | 2018 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2015 | 7 | |
| 18 | 2016 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2025 | 1 |
About Che Lin
Che Lin is a scholar working on Cancer Research, Toxicology, Genetics, Health, Toxicology and Mutagenesis and Pathology and Forensic Medicine, having authored 20 papers that have together received 412 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Estrogen and related hormone effects (6 papers), Bioactive Compounds and Antitumor Agents (5 papers), Breast Cancer Treatment Studies (4 papers), Phytochemicals and Antioxidant Activities (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Breast Lesions and Carcinomas (2 papers) and Toxic Organic Pollutants Impact (2 papers). The work is most often cited by research in Cancer Research (106 citations), Biochemistry (41 citations), Toxicology (22 citations), Health, Toxicology and Mutagenesis (54 citations) and Pathology and Forensic Medicine (33 citations). Che Lin has collaborated with scholars based in Taiwan and China. Frequent co-authors include Dar‐Ren Chen, Shou‐Jen Kuo, Li-Sheng Chen, Po-Hsiung Lin, C.‐C. Tsai, Ta‐Chen Lin, Kuen‐Yao Ho, Shou‐Tung Chen, Li‐Hsuan Wang and Hsiu‐Chen Lin. Their work appears in journals such as Toxicology Letters, BMC Cancer, Journal of Environmental Science and Health Part A, Cancer Chemotherapy and Pharmacology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.